Posts for Ticker ‘BG’

Top Day Trader Alerts (CIT, ANDS, AVNR, BG, ANPI, RINO)

These are this morning’s top day trader alert and actively traded stocks.  We have links through to each with more detailed price and volume data and analysis over at VSInvestor.com:

CIT Group, Inc. (NYSE: CIT) is down over 20% after it delayed its 10-Q filing amid restructuring.  Worse talk is out there…

Anadys Pharma (NASDAQ: ANDS) is up 30% or more on early clinical trial in Hepatitis C patient data.

Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) is hitting 52-week highs after showing positive Phase III study results for Zenvia.

Bunge Limited (NYSE: BG) is down 4% on a surprise secondary offering.

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI) is up over 30% as a license holder reported a CE Mark approval.

RINO International Corporation (NASDAQ: RINO) was very active last night after earnings and is down 17% this morning.

JON C. OGG
AUGUST 11, 2009

Top Pre-Market Analyst Downgrades (BRY, BBG, BG, CBST, GSX, KNL, WFR, SIRO, TXCO)

These are the top pre-market downgrades from Wall Street analysts this Friday morning:

  • Berry Petroleum (BRY) Cut to Market Perform at Morgan Keegan.
  • Bill Barrett (BBG) Cut to Market Perform at Morgan Keegan.
  • Bunge (BG) Cut to Underperform at Merrill Lynch.
  • Cubist Pharma (CBST) Cut to Perform at Oppenheimer.
  • Gasco Energy (GSX) Cut to Market Perform at Morgan Keegan.
  • Knoll (KNL) Cut to Sell at Goldman Sachs.
  • MEMC (WFR) Started as Underweight at Morgan Stanley.
  • Sirona Dental (SIRO) Cut to Neutral at Baird.
  • TXCO Resources (TXCO) Cut to Market Perform at Morgan Keegan.

Jon C. Ogg
December 5, 2008

Bunge (BG) Bets The Farm, Doubles Down On Corn

Bunge (BG), which has a big business in finished corn products, is buying Corn Products International (CPO) for $4.4 billion. CPO’s name pretty much says how it makes its money.

The price is a 25% premium to the Corn Product’s recent share price, which is an awful risk for Bunge. According to The Wall Street Journal, "Buying Corn Products will give Bunge a presence in nearly every step of the so-called corn value chain."

The fact that the price of corn and other agricultural commodities is rising could be viewed as good for Bunge. It could also be viewed as very, very bad.

Bunge and its peers are operating in a market where corn price have spiked up 20% in recent weeks due to flooding in the Midwest. The rise in the commodity may allow Bunge to increase revenue, but it may quickly lose the opportunity to pass along the costs of raw goods to its customers. As the price of corn flakes and bread moves up, consumers may simply buy less. Bunge and Corn Products customers like Kellogg (K) and Coca-Cola (KO) may not be able to increase sales as expensive corn bread drives people to find food alternatives which as not as expensive.

Wall St. has started to catch on to the substantial gross margin risks at Bunge. Its shares are only up about 5% so far this year. Bunge is getting caught in the food inflation cycle and its earnings could be damaged as the second half of the year comes around. The CPO deal may end up as an example of how a fool and his money are soon parted.

Douglas A. McIntyre

Top 10 Pre-Market Analyst Calls (AZN, BG, CCJ, CFC, DWSN, INAP, LAMR, MNST, NCC, SGEN)

Below are the ten analyst calls that 247WallSt.com is focusing on in pre-market trading this Wednesday morning:

  • AstraZeneca (NYSE: AZN) raised to Overweight at HSBC Securities.
  • Bunge (NYSE: BG) raised to Overweight at JPMorgan.
  • Cameco (NYSE: CCJ) cut to Hold at TD.
  • Countrywide Financial (NYSE: CFC) raised to Market Perform at Wachovia.
  • Dawson Geophysical (NASDAQ: DWSN) started as Hold at Jefferies.
  • InterNAP (NASDAQ: INAP) cut to Neutral at Merriman Curhan Ford.
  • Lamar Advertising (NASDAQ: LAMR) cut to Underweight at JP Morgan.
  • Monster Worldwide (NASDAQ: MNST) cut to Neutral at JPMorgan.
  • National City (NYSE: NCC) Raised to Sector Perform at RBC
  • Seattle Genetics (NASDAQ: SGEN) raised to Outperform at RBC Capital Markets.

Jon C. Ogg
March 19, 2008

Crops & Ag Pulling Back; Buying Opportunity Or Just Starting? (MOS, POT, MON, BG, ADM, MOO)

When you see sectors that have been key leaders fall it’s often just another buying opportunity.  But when you start seeing an exodus you have to wonder if letting the good times roll is smart. In this market there are very few safe havens. That is particularly true if new valuation metrics being reevaluated come true.  Enter agriculture and fertilizer.  The charts on these are not indicating any major uptrend violations,although by now you know they never do until they already have (sorry for theredundant jab).

The potash sector has been hot until today.  Today, shares of Mosaic Co. (NYSE: MOS) is leading the sector lower with a 6% drop to under $103.00, up from a 52-week lows of under $20.00.  Potash Corp. of Saskatchewan, Inc. (NYSE: POT) is down over 3.7% at $144.50, although its 52-week low is $45.82.

Monsanto (NYSE: MON) is down almost 2% to $124.85, and its 52-week low is $50.01.  Share of Bunge Ltd. (NYSE:BG) are down 3.3% to $128.55, up from its 52-week low of 70.97.

Maybe with the DJIA trading down another 200 points there just aren’t any safe havens.  Even the core defensive go-to stocks have been trading lower today and we noted some higher valuations starting to look like a premium at the time.

Archer-Daniels-Midland (NYSE: ADM) is bucking today’s trend as it is down less than 0.4% at $45.00, up from a 52-week low of $30.46.  The fairly new ETF in the sector is the  Market Vectors Global Agribusiness ETF (AMEX: MOO), and it is down some 2.8% to $57.76.  Since coming public late in 2007 it has traded as low as $40.19 and as high as $59.49, so it isn’t exactly looking like hard troubles are setting in yet.

The ethanol competition for food is a real one and most of these fertilizer and potash companies have discussed major pricing power.  We’ll be keeping an eye on this sector as this has been perhaps the brightest spot in the market that traders have traditionally ignored.

Jon C. Ogg
January 15, 2008

Pre-Market Analyst Calls (October 26, 2007)

ABK cut to Mkt Perform at FBR.
ADVNA cut to Mkt Perform at FBR.
BBY started as Mkt Perform at Wachovia.
BEN cut to Mkt PErform at FBR.
BG cut to Neutral at HSBC.
CC started as Mkt Perform at Wachovia.
CPS cut to Equal Weight at Lehman.
ELX cut to Mkt Perform at FBR.
ETEL cut to Mkt Perform at JMP Securities.
EXBD raised to Buy at Deutsche Bank.
FADV cut to Equal Weight at Lehman.
FVE raised to Buy at Jefferies.
GIS raised to Buy at Deutsche Bank.
HES raised to Buy at B of A.
KND raised to Buy at Jefferies.
LVLT cut to Neutral at JPMorgan.
LTM cut to Mkt Perform at Piper Jaffray.
MBI cut to Mkt Perform at FBR.
NILE raised to Hold at Citigroup.
ORCC cut to Sector Perform at CIBC.
PENN cut to Hold at Jefferies.
POWI cut to Hold at Citigroup.
RRI started as outperform at Wachovia.
SE started as Mkt Perform at Wachovia.
STD raised to Buy at Citigroup.
STLD cut to Neutral at UBS.
TRID too 3 downgrades: Jefferies, Deutsche Bank, and Oppenheimer.
TSM raised to Overweight at HSBC.
USU started as Mkt Perform at Wachovia.
WCG raised to Neutral at Goldman Sachs.

Jon C. Ogg
October 26, 2007

Morningstar’s Seven Stocks To Sell

Morningstar has hit the market with "The Market’s Most Overvalued Stocks". They cover a wide range of industries, and some of them, like Schlumberger (SLB), would appear to be "buys" right now.

In addition to the oil and gas services company, the list includes: Sun Micro (JAVA), Bunge (BG), TD Ameritrade (AMTD), Celgene (CELG), Lowes Corporation (LTR), and AT&T (T).

Douglas A. McIntyre